Literature DB >> 12470805

Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.

John P Blass1.   

Abstract

Much of the controversy about the "amyloid cascade hypothesis" may reflect unrecognized differences in the use of language, including the use of the word "cause." This commentary proposes that the term Alzheimer disease refer to the neuropathological entity and the term Alzheimer dementia to clinical dementia in people who also have Alzheimer neuropathology. The ultimate causes of Alzheimer disease are proposed to be aging, environmental stresses, and genetic predispositions. The fundamental cause of Alzheimer dementia is proposed to be Alzheimer disease, i.e. the neurobiological abnormalities in Alzheimer brain. The neurobiology of Alzheimer disease includes changes that may initially be adaptive but can become excessive and thereby harmful; they include increased expression of APP with accumulation of potentially damaging peptides such as Abeta, inflammation, and increased ROS activity. The neurobiological abnormality that is the proximate cause of Alzheimer dementia appears to be decreases in cerebral metabolic rate. Decreased metabolism occurs not only in this but in essentially all dementias, and impairing brain metabolism induces neuropsychological deficits characteristic of dementias. The immediate cause of Alzheimer dementia is proposed to be deficiencies in signaling, both intracellular and intercellular (neurotransmission), that follow directly from the decrease in cerebrometabolic rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470805     DOI: 10.1016/s0197-4580(02)00036-2

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

1.  Involvement of α7 nAChR signaling cascade in epigallocatechin gallate suppression of β-amyloid-induced apoptotic cortical neuronal insults.

Authors:  Xijing Zhang; Mingmei Wu; Fan Lu; Na Luo; Zu-Ping He; Hao Yang
Journal:  Mol Neurobiol       Date:  2013-06-27       Impact factor: 5.590

Review 2.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Authors:  Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.

Authors:  Lisa Mosconi
Journal:  Clin Transl Imaging       Date:  2013-08

Review 4.  The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

Authors:  Sally Hunter; Thomas Arendt; Carol Brayne
Journal:  Mol Neurobiol       Date:  2013-04-03       Impact factor: 5.590

Review 5.  FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Authors:  L Mosconi; P F McHugh
Journal:  Q J Nucl Med Mol Imaging       Date:  2011-06       Impact factor: 2.346

Review 6.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  Involvement of α7nAChR in the Protective Effects of Genistein Against β-Amyloid-Induced Oxidative Stress in Neurons via a PI3K/Akt/Nrf2 Pathway-Related Mechanism.

Authors:  Jianbin Guo; Guoqing Yang; Yuqing He; Huiming Xu; Hong Fan; Jing An; Lingling Zhang; Rui Zhang; Guihua Cao; Dingjun Hao; Hao Yang
Journal:  Cell Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.046

Review 8.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

9.  What have novel imaging techniques revealed about metabolism in the aging brain?

Authors:  Ai-Ling Lin; Douglas L Rothman
Journal:  Future Neurol       Date:  2014-05-01

10.  Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8).

Authors:  Xuezhu Zhang; Guomin Li; Lin Guo; Kun Nie; Yujie Jia; Lan Zhao; Jianchun Yu
Journal:  Neurol Sci       Date:  2013-04-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.